RGEN
USDRepligen Corporation Common Stock
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$149.060
الأعلى
$151.250
الأدنى
$146.000
الحجم
0.61M
أساسيات الشركة
القيمة السوقية
8.3B
الصناعة
Medical Instruments & Supplies
البلد
United States
إحصاءات التداول
متوسط الحجم
0.92M
البورصة
NMS
العملة
USD
نطاق 52 أسبوعاً
أخبار ذات صلة
Repligen Corporation to Present at Upcoming November Conferences
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165
Canaccord Genuity analyst Kyle Mikson maintains Repligen with a Hold and raises the price target from $150 to $165.
Barclays Maintains Overweight on Repligen, Raises Price Target to $175
Barclays analyst Luke Sergott maintains Repligen with a Overweight and raises the price target from $160 to $175.
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchisesOrders increased sequentially and greater than 20% year-over-yearIncreasing
Repligen to Report Third Quarter 2025 Financial Results
WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial results on Tuesday, October 28, 2025. The Company will
أسهم ذات صلة
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.